Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo Xinwan Technology Development
Ningbo, Zhejiang, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Xinwan Biopharma, officially registered as Ningbo Xinwan Technology Development, is a Chinese biotechnology company dedicated to the development of mRNA-based therapeutics and vaccines. The company utilizes a proprietary lipid nanoparticle (LNP) delivery platform and advanced mRNA sequence design to create a pipeline targeting infectious diseases and oncology. Its lead candidate, SW-001, is an mRNA vaccine for COVID-19 that has progressed into Phase 2 clinical trials. Beyond vaccines, Xinwan is exploring mRNA applications in protein replacement therapies and cancer immunotherapy. The company is headquartered in the Ningbo Hi-Tech Zone and maintains close ties with regional research institutes to accelerate its R&D efforts. Xinwan aims to provide high-quality, domestically produced nucleic acid medicines for the global market.
- Therapeutic areas
- Infectious DiseasesOncology
- Modalities
- mRNA-based drugsBiologicVaccineLipid nanoparticle delivery therapy
- Industry
- Biotech
02
Partnerships
Ningbo New Bay Institute of Biopharmaceuticals
Beyond the preview
Go deeper on Ningbo Xinwan Technology Development.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ningbo Xinwan Technology Development.